U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C45H58N10O13
Molecular Weight 947.0012
Optical Activity UNSPECIFIED
Defined Stereocenters 11 / 11
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NEPADUTANT

SMILES

CC(C)C[C@@H]1NC(=O)[C@@H]2CNC(=O)C[C@H](NC(=O)[C@H](CC(=O)N[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3NC(C)=O)NC1=O)C(=O)N[C@@H](CC4=CNC5=C4C=CC=C5)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)N2

InChI

InChIKey=NGCNKEZHGRXHNL-WVWQGFTISA-N
InChI=1S/C45H58N10O13/c1-21(2)13-27-39(62)53-31(17-35(59)55-45-36(48-22(3)57)38(61)37(60)33(20-56)68-45)43(66)52-30-16-34(58)47-19-32(44(67)49-27)54-40(63)28(14-23-9-5-4-6-10-23)50-41(64)29(51-42(30)65)15-24-18-46-26-12-8-7-11-25(24)26/h4-12,18,21,27-33,36-38,45-46,56,60-61H,13-17,19-20H2,1-3H3,(H,47,58)(H,48,57)(H,49,67)(H,50,64)(H,51,65)(H,52,66)(H,53,62)(H,54,63)(H,55,59)/t27-,28-,29-,30-,31-,32-,33+,36+,37+,38+,45+/m0/s1

HIDE SMILES / InChI

Molecular Formula C45H58N10O13
Molecular Weight 947.0012
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 11 / 11
E/Z Centers 1
Optical Activity UNSPECIFIED

Menarini was developing oral nepadutant (MEN 11420), a potent and selective tachykinin neurokinin-2 receptor antagonist, for the treatment of infant colic. Nepadutant has been used in trials studying the treatment of colic, infantile colic, and infantile functional gastrointestinal disorders. MEN 11420 is a glycosylated derivative of the potent, selective, conformationally-constrained tachykinin NK2 receptor antagonist MEN 10627. MEN 11420 competitively bound with high affinity to the human NK2 receptor stably transfected in CHO cells, displacing radiolabelled [125I]-neurokinin A and [3H]-SR 48968 with Ki values of 2.5+/-0.7 nM (n = 6) and 2.6+/-0.4 nM (n = 3), respectively.

Approval Year

PubMed

PubMed

TitleDatePubMed
MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
1998 Jan
Nepadutant pharmacokinetics and dose-effect relationships as tachykinin NK2 receptor antagonist are altered by intestinal inflammation in rodent models.
2001 Oct
Pharmacology of an original and selective nonpeptide antagonist ligand for the human tachykinin NK2 receptor.
2005 Jun 1
MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
2006 Nov 7

Sample Use Guides

Infantile Colic: 0.1 - 0.5 mg/Kg as one single oral dose divided in three age strata (from 6 to 24 weeks old)
Route of Administration: Oral
In Vitro Use Guide
Nepadutant (MEN 11420) competitively bound with high affinity to the human NK2 receptor stably transfected in CHO cells, displacing radiolabelled [125I]-neurokinin A and [3H]-SR 48968 with Ki values of 2.5±0.7 nM (n=6) and 2.6±0.4 nM (n=3), respectively. In the rabbit isolated pulmonary artery and rat urinary bladder MEN 11420 potently and competitively antagonized tachykinin NK2 receptor-mediated contractions (pKB=8.6±0.07, n=10, and 9.0±0.04, n=12; Schild plot slope=−1.06 (95% c.l.=−1.3; −0.8) and −1.17 (95% c.l.=−1.3; −1.0), respectively). MEN 11420 produced an insurmountable antagonism at NK2 receptors in the hamster trachea and mouse urinary bladder. However, in both preparations, the effect of MEN 11420 was reverted by washout and an apparent pKB of 10.2±0.14, n= 9, and 9.8±0.15, n=9, was calculated in the hamster trachea and mouse urinary bladder, respectively.
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:16:38 UTC 2023
Edited
by admin
on Fri Dec 15 16:16:38 UTC 2023
Record UNII
XW59TYL1XH
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NEPADUTANT
INN  
INN  
Official Name English
CYCLO(N-(2-ACETAMIDO-2-DEOXY-.BETA.-D-GLUCOPYRANOSYL)-L-ASPARAGINYL-L-.ALPHA.-ASPARTYL-L-TRYPTOPHYL-L-PHENYLALANYL-L-2,3-DIAMINOPROPIONYL-L-LEUCYL),CYCLIC(2-5)-PEPTIDE
Common Name English
nepadutant [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C29712
Created by admin on Fri Dec 15 16:16:38 UTC 2023 , Edited by admin on Fri Dec 15 16:16:38 UTC 2023
Code System Code Type Description
FDA UNII
XW59TYL1XH
Created by admin on Fri Dec 15 16:16:38 UTC 2023 , Edited by admin on Fri Dec 15 16:16:38 UTC 2023
PRIMARY
ChEMBL
CHEMBL1908318
Created by admin on Fri Dec 15 16:16:38 UTC 2023 , Edited by admin on Fri Dec 15 16:16:38 UTC 2023
PRIMARY
EVMPD
SUB09196MIG
Created by admin on Fri Dec 15 16:16:38 UTC 2023 , Edited by admin on Fri Dec 15 16:16:38 UTC 2023
PRIMARY
DRUG BANK
DB12538
Created by admin on Fri Dec 15 16:16:38 UTC 2023 , Edited by admin on Fri Dec 15 16:16:38 UTC 2023
PRIMARY
NCI_THESAURUS
C84001
Created by admin on Fri Dec 15 16:16:38 UTC 2023 , Edited by admin on Fri Dec 15 16:16:38 UTC 2023
PRIMARY
CAS
183747-35-5
Created by admin on Fri Dec 15 16:16:38 UTC 2023 , Edited by admin on Fri Dec 15 16:16:38 UTC 2023
PRIMARY
EPA CompTox
DTXSID801032036
Created by admin on Fri Dec 15 16:16:38 UTC 2023 , Edited by admin on Fri Dec 15 16:16:38 UTC 2023
PRIMARY
SMS_ID
100000084173
Created by admin on Fri Dec 15 16:16:38 UTC 2023 , Edited by admin on Fri Dec 15 16:16:38 UTC 2023
PRIMARY
INN
7719
Created by admin on Fri Dec 15 16:16:38 UTC 2023 , Edited by admin on Fri Dec 15 16:16:38 UTC 2023
PRIMARY
PUBCHEM
9876321
Created by admin on Fri Dec 15 16:16:38 UTC 2023 , Edited by admin on Fri Dec 15 16:16:38 UTC 2023
PRIMARY
WIKIPEDIA
Nepadutant
Created by admin on Fri Dec 15 16:16:38 UTC 2023 , Edited by admin on Fri Dec 15 16:16:38 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY